Session # P037, Group 1

Reduced risk BRCA1 and BRCA2 variants: Insight into classification of concordant variants between two commercial laboratories

The identification and reporting of reduced risk BRCA1 and BRCA2 (RR-BRCA) variants is complex and poses challenges for patient counseling. We sought to compile and compare data for RR-BRCA variants reported by two clinical diagnostic laboratories.

• Authors: Tuya Pal, MD; Marcy Richardson, PhD; Tina Pesaran, MS, CGC; Elizabeth Chao, MD, FACMG
• Collaborators: Mayo Clinic; Moffitt Cancer Center; Myriad Women's Health
• Conference: BRCA Symposium 2023
• Date: Tuesday, May 02, 2023 2:45pm - 4:15pm